Clinical trials exclude disabled Americans because federal agencies failed them, new report finds
People with disabilities are largely excluded from clinical trials that could benefit them because federal agencies have failed to update rules that govern how trials are conducted or neglected to enforce existing laws that protect disabled Americans against discrimination, a new report has found.
The National Council on Disability, an independent federal agency, released the report this week detailing how several federal agencies implicitly and explicitly exclude people with disabilities from clinical trials. The report singled out several agencies including the Food and Drug Administration, National Institutes of Health, Health and Human Services and Department of Justice.
